Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miguel Mansilla‐Polo
Observed names:
M. Mansilla-Polo,
Mansilla Polo, Miguel,
Mansilla-Polo, Miguel,
Miguel Mansilla Polo,
Miguel Mansilla-Polo
Institutions:
Hospital Universitari i Politècnic La Fe,
Instituto de Investigación Sanitaria La Fe
Observed institutions:
Universitat de València,
Westmead Hospital,
Hospital Universitari i Politècnic La Fe,
Instituto Murciano de Investigación Biosanitaria,
Hospital Universitario Virgen de la Arrixaca,
Instituto de Investigación Sanitaria La Fe
show all 6
ORCID:
0000-0001-6730-6723
Observed ORCID:
0000-0001-6730-6723
OpenAlex ID:
A5091394692
Biologics Versus JAK Inhibitors. Part II: Risk of Infections. A Narrative Review
2024
·
Miguel Mansilla-Polo
, Daniel Morgado-Carrasco
·
Dermatology and Therapy
·
49
Refractory cutaneous lupus erythematosus successfully treated with anifrolumab: a case series
2024
·
Daniel Martín‐Torregrosa
, Miguel Mansilla‐Polo
, et al.
·
International Journal of Dermatology
·
17
Skin cancer risk after hematopoietic stem cell transplantation: a systematic review and meta‐analysis
2024
·
Miguel Mansilla‐Polo
, Javier López‐Davia
, et al.
·
International Journal of Dermatology
·
16
PDF
Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review
2024
·
Miguel Mansilla-Polo
, Daniel Morgado-Carrasco
·
Dermatology and Therapy
·
16
[Translated article] Use of Anifrolumab in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, and Other Autoimmune Dermatoses
2024
·
D. Martín-Torregrosa
, M. Mansilla-Polo
, et al.
·
Actas Dermo-Sifiliográficas
·
15
Successful Treatment of Stimulator of Interferon Genes–Associated Vasculopathy of Infantile Onset SAVI Syndrome With Anifrolumab
2024
·
Miguel Mansilla-Polo
, Daniel Martín-Torregrosa
, et al.
·
JAMA Dermatology
·
14
[Translated aticle] Topical and Oral Roflumilast in Dermatology: A Narrative Review
2024
·
M. Mansilla-Polo
, E. Gimeno
, et al.
·
Actas Dermo-Sifiliográficas
·
14
Real‐world effectiveness and safety of bimekizumab for hidradenitis suppurativa: An ambispective observational study
2024
·
Miguel Mansilla‐Polo
, Martí Pons‐Benavent
, et al.
·
Australasian Journal of Dermatology
·
13
PDF
Narrative Review and Update on Biologic and Small Molecule Drugs for Hidradenitis Suppurativa: An Entity With a Promising Future
2023
·
M. Mansilla-Polo
, B. Escutia-Muñoz
, et al.
·
Actas Dermo-Sifiliográficas
·
13
Cavity shaving for invasive breast cancer conservative surgery: Reduced specimen volume and margin positive rates
2021
·
Miguel Mansilla-Polo
, Guadalupe Ruiz-Merino
, et al.
·
Surgical Oncology
·
13
Review on the Role of Paraffin-embedded Margin-controlled Mohs Micrographic Surgery to Treat Skin Tumors
2024
·
M. Mansilla-Polo
, D. Morgado-Carrasco
, et al.
·
Actas Dermo-Sifiliográficas
·
12
Effectiveness, safety and satisfaction of 1% tirbanibulin ointment in the treatment of actinic keratoses: A prospective study in real clinical practice
2023
·
Miguel Mansilla‐Polo
, Carlos Abril‐Pérez
, et al.
·
Australasian Journal of Dermatology
·
12
PDF
Phytophotodermatitis as a clinical problem and as a therapeutic option: Case report and review of the literature
2023
·
Miguel Mansilla-Polo
, Daniel Martín-Torregrosa
, et al.
·
Photodiagnosis and Photodynamic Therapy
·
12
Chronic graft-versus-host disease in the era of post-transplant cyclophosphamide
2026
·
Pedro Asensi Cantò
, Juan Montoro
, et al.
·
Haematologica
·
11
PDF
Dermatological toxicities of talquetamab, a new bispecific antibody: case series and literature review
2024
·
Miguel Mansilla‐Polo
, Daniel Martín‐Torregrosa
, et al.
·
JDDG Journal der Deutschen Dermatologischen Gesellschaft
·
11
Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study ( REGESMOHS , Spanish registry of Mohs surgery)
2024
·
Carlos Abril‐Pérez
, Miguel Mansilla‐Polo
, et al.
·
Journal of the European Academy of Dermatology and Venereology
·
11
PDF
Long-Term Effectiveness and Safety of Bimekizumab in Patients with Moderate to Severe Hidradenitis Suppurativa Under Real Clinical Practice Conditions: The Importance of Combined Treatment in Hurley III Patients and Potential Factors Associated with Complete Response
2025
·
Miguel Mansilla-Polo
, Carmen García-Moronta
, et al.
·
Dermatology and Therapy
·
10
PDF
Dietas populares y su impacto en la piel. Una revisión narrativa
2023
·
M. Mansilla-Polo
, J. Piquero-Casals
, et al.
·
Actas Dermo-Sifiliográficas
·
10
[Artículo traducido] Revisión narrativa y actualización en fármacos biológicos y de pequeña molécula para el tratamiento de la hidradenitis supurativa: una entidad con un futuro prometedor
2023
·
M. Mansilla-Polo
, B. Escutia-Muñoz
, et al.
·
Actas Dermo-Sifiliográficas
·
9
Mohs Micrographic Surgery and Improved Survival in Skin Cancer: A Narrative Review
2025
·
Pablo Balado-Simó
, Miguel Mansilla-Polo
, et al.
·
Dermatology and Therapy
·
7
PDF
Successful treatment of erythema nodosum leprosum with upadacitinib and roflumilast
2024
·
Miguel Mansilla‐Polo
, Carlos Abril‐Pérez
, et al.
·
International Journal of Dermatology
·
7
Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment
2023
·
Carlos Abril-Pérez
, Miguel Mansilla-Polo
, et al.
·
Clinical and Experimental Dermatology
·
7
Incidence and Risk Factors of Skin Cancer and Preneoplastic Lesions after Autologous and Allogeneic Hematopoietic Cell Transplantation
2025
·
Miguel Mansilla-Polo
, Juan Montoro
, et al.
·
Transplantation and Cellular Therapy
·
6
Successful Treatment of Mogamulizumab-Associated Rash With Upadacitinib: Evidence From 2 Cases
2024
·
Daniel Martín-Torregrosa
, Ignacio Torres-Navarro
, et al.
·
JAMA Dermatology
·
6
Recalcitrant Hailey–Hailey Disease With Satisfactory Response to Apremilast
2023
·
M. Mansilla-Polo
, C. Abril-Pérez
, et al.
·
Actas Dermo-Sifiliográficas
·
6
Show more works
View as search
Works count:
187
Citation count:
415
H-index:
12
I10-index:
18
Year
Topic
Type